146428 -OEChem-03010813452D 7 0 0 0 0 0 0 0 0999 V2000 -0.0250 1.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 0.5000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 0.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -0.5000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -1.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -1.5000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -2.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 A 1 R A 2 R A 3 R A 4 R A 5 R A 6 R A 7 R M END > 0 > 0 > 146428 > 1 > DTP/NCI > 294736 > Development Therapeutics Program NCI/NIH > Composition for every 0.2 ml H(2)O: 1.23 mg sodium sulfite, KOH to pH 9.3-9.5, 0.0170 mg p-tert butyl catechol, 0.0023 mg 1, 2-naphthoquinone, 0.1473 mg catechol, 0.0490 mg 2,5-dihydroxy p-quinone, 0.2450 mg tetrahydroxyquinone, 0.2940 mg tetrahydroxyquinone polymer, 0.0810 mg croconic acid, 0.1643 mg croconic acid polymer NSC294736 > NSC294736 > http://dtp.nci.nih.gov/ > http://dtp.nci.nih.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=294736 $$$$